Home
Emergent BioSolutions EBS paid Forbes-Tate $60K for lobbying in Q4 2022 · Health Issues, Budget
Trade details
- Type
- Lobbying report
- Amount
- $60,000
- Quarter
- Q4 2022
- Client
- Emergent Biosolutions
- Reported
- 23/01/15
$1M on lobbying in 2022
What else happened in Emergent BioSolutions around then
Filed or reported within 30 days of the trade day · 22/12/01~23/01/30Emergent Biosolutions's other lobbying reports
- Emergent Biosolutions
LobbyingEmergent BioSolutions
LobbyingEmergent BioSolutions
EBS
$70K
$70K
Reported 07/19
for Q2
- Emergent Biosolutions
LobbyingEmergent BioSolutions
LobbyingEmergent BioSolutions
EBS
$40K
$40K
Reported 07/15
for Q2
- Emergent Biosolutions
LobbyingEmergent BioSolutions
LobbyingEmergent BioSolutions
EBS
$510K
$510K
Reported 07/14
for Q2
- Emergent Biosolutions
LobbyingEmergent BioSolutions
LobbyingEmergent BioSolutions
EBS
$50K
$50K
Reported 07/08
for Q2
- Emergent Biosolutions
LobbyingEmergent BioSolutions
LobbyingEmergent BioSolutions
EBS
$70K
$70K
Reported 04/20
for Q1